Good Luck Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 25-07-2024
- Paid Up Capital ₹ 1.00 M
as on 25-07-2024
- Company Age 32 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.40 M
as on 25-07-2024
- Satisfied Charges ₹ 0.30 M
as on 25-07-2024
- Revenue 6.90%
(FY 2023)
- Profit 10.15%
(FY 2023)
- Ebitda 7.86%
(FY 2023)
- Net Worth 3.20%
(FY 2023)
- Total Assets 14.57%
(FY 2023)
About Good Luck Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.40 M. The company has closed loans amounting to ₹0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Maheshwari, Sanjeev Maheshwari, and Alka Maheshwari serve as directors at the Company.
- CIN/LLPIN
U24231UP1992PTC014483
- Company No.
014483
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jun 1992
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Uttar Pradesh, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Good Luck Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Maheshwari  | Managing Director | 22-Jun-1992 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Alka Maheshwari | Director | 22-Jun-1992 | Current |
| Sanjeev Maheshwari | Director | 22-Jun-1992 | Current |
Financial Performance of Good Luck Pharma.
Good Luck Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.9% increase. The company also saw a substantial improvement in profitability, with a 10.15% increase in profit. The company's net worth moved up by a moderate rise of 3.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Good Luck Pharma?
In 2023, Good Luck Pharma had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Swaroop Pharmaceuticals Private LimitedActive 26 years 7 monthsSanjay Maheshwari is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 14 Mar 2009 | ₹1.40 M | Open |
Bob Creation Date: 24 Nov 1994 | ₹1.00 M | Open |
Bob Creation Date: 24 Nov 1994 | ₹1.00 M | Open |
How Many Employees Work at Good Luck Pharma?
Unlock and access historical data on people associated with Good Luck Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Good Luck Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Good Luck Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
